drugset / Trial / NCT07008443
An Integrated Artificial Intelligence Approach for Predicting Analgesic Time Based on Nalbuphine Versus Morphine as Adjuvants to Bupivacaine in Ultrasound-Guided Supraclavicular Block
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study investigated the effect of adding nalbuphine or morphine to bupivacaine for supraclavicular brachial plexus block in upper limb surgeries. Sixty adult patients were randomized into three groups: control (bupivacaine + saline), nalbuphine, and morphine. The primary objective was to compare the duration of analgesia between the groups. A secondary goal was to assess whether artificial intelligence (AI), specifically the k-nearest neighbor (KNN) algorithm, could predict analgesic duration based on patient clinical and demographic data. The study concluded that both nalbuphine and morphine significantly prolonged analgesic duration and that the AI model showed high predictive accuracy.
Timeline
- Start
- 2024-01-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 50 ug/kg | Other |
| Subject | Nalbuphine | Small molecule | 50 ug/kg | Other |
| Comparator | Bupivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 25 ml | Other |
Indications
No indication recorded.